Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,510
Total Claims
$1.2M
Drug Cost
793
Beneficiaries
$1,535
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+98%
Opioid rate vs peers
7.5% vs 3.8% avg
+31%
Cost per patient vs peers
$1,535 vs $1,174 avg
+36%
Brand preference vs peers
12.1% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.5%
Opioid Rate
861
Opioid Claims
$20K
Opioid Cost
5.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,378 claims · $985K
Generic: 10,024 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 247 | $303K |
| Insulin Degludec | 71 | $114K |
| Apixaban | 83 | $71K |
| Insulin Lispro | 54 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 67 | $48K |
| Insulin Degludec | 67 | $36K |
| Sitagliptin Phosphate | 21 | $34K |
| Insulin Aspart | 36 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $27K |
| Insulin Lispro | 16 | $26K |
| Insulin Detemir | 28 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 35 | $14K |
| Tiotropium Bromide | 11 | $13K |
| Estrogens, Conjugated | 23 | $13K |
Prescribing Profile
Patient Profile
73
Avg Age
69%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About